Equities researchers at StockNews.com initiated coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a research report issued on Saturday. The brokerage set a “hold” rating on the medical research company’s stock.
Accelerate Diagnostics Stock Up 7.1 %
AXDX stock opened at $1.95 on Friday. The business has a 50 day moving average of $1.63 and a 200 day moving average of $1.26. The firm has a market cap of $43.00 million, a PE ratio of -0.48 and a beta of 0.61. Accelerate Diagnostics has a twelve month low of $0.73 and a twelve month high of $7.00.
Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The medical research company reported ($0.50) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.05. The company had revenue of $2.99 million during the quarter, compared to analysts’ expectations of $3.00 million. On average, research analysts expect that Accelerate Diagnostics will post -2.14 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
About Accelerate Diagnostics
Accelerate Diagnostics, Inc, an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.
Featured Articles
- Five stocks we like better than Accelerate Diagnostics
- 3 Warren Buffett Stocks to Buy Now
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Investing in Construction Stocks
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Accelerate Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accelerate Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.